Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.

Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, Verneris MR, Kaufman DS.

Blood. 2009 Jun 11;113(24):6094-101. doi: 10.1182/blood-2008-06-165225. Epub 2009 Apr 13.

2.

Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.

Cany J, van der Waart AB, Tordoir M, Franssen GM, Hangalapura BN, de Vries J, Boerman O, Schaap N, van der Voort R, Spanholtz J, Dolstra H.

PLoS One. 2013 Jun 5;8(6):e64384. doi: 10.1371/journal.pone.0064384. Print 2013.

3.

Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells.

Martin CH, Woll PS, Ni Z, Zúñiga-Pflücker JC, Kaufman DS.

Blood. 2008 Oct 1;112(7):2730-7. doi: 10.1182/blood-2008-01-133801. Epub 2008 Jul 11.

4.

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.

Spanholtz J, Tordoir M, Eissens D, Preijers F, van der Meer A, Joosten I, Schaap N, de Witte TM, Dolstra H.

PLoS One. 2010 Feb 15;5(2):e9221. doi: 10.1371/journal.pone.0009221.

5.

Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells.

Tian X, Hexum MK, Penchev VR, Taylor RJ, Shultz LD, Kaufman DS.

Stem Cells. 2009 Nov;27(11):2675-85. doi: 10.1002/stem.204.

6.

Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity.

Tian X, Woll PS, Morris JK, Linehan JL, Kaufman DS.

Stem Cells. 2006 May;24(5):1370-80. Epub 2006 Feb 2.

7.

Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.

Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS.

J Virol. 2011 Jan;85(1):43-50. doi: 10.1128/JVI.01774-10. Epub 2010 Oct 20.

8.

Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity.

Woll PS, Martin CH, Miller JS, Kaufman DS.

J Immunol. 2005 Oct 15;175(8):5095-103.

9.

Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.

Li Y, Qu YH, Wu YF, Wang XP, Wei J, Huang WG, Zhou DH, Fang J, Huang K, Huang SL.

Ann Hematol. 2011 Aug;90(8):873-85. doi: 10.1007/s00277-011-1156-9. Epub 2011 Jan 15.

PMID:
21234566
10.

Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells.

Kalberer CP, Siegler U, Wodnar-Filipowicz A.

Blood. 2003 Jul 1;102(1):127-35. Epub 2003 Mar 13.

11.

Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy.

Knorr DA, Bock A, Brentjens RJ, Kaufman DS.

Stem Cells Dev. 2013 Jul 1;22(13):1861-9. doi: 10.1089/scd.2012.0608. Epub 2013 Mar 28.

12.

Ex vivo generated natural killer cells acquire typical natural killer receptors and display a cytotoxic gene expression profile similar to peripheral blood natural killer cells.

Lehmann D, Spanholtz J, Osl M, Tordoir M, Lipnik K, Bilban M, Schlechta B, Dolstra H, Hofer E.

Stem Cells Dev. 2012 Nov 1;21(16):2926-38. doi: 10.1089/scd.2011.0659. Epub 2012 Jul 17.

13.

Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Wang D, Quan Y, Yan Q, Morales JE, Wetsel RA.

Stem Cells Transl Med. 2015 Oct;4(10):1234-45. doi: 10.5966/sctm.2015-0049. Epub 2015 Aug 18.

14.
15.
16.

Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.

Turner JG, Rakhmilevich AL, Burdelya L, Neal Z, Imboden M, Sondel PM, Yu H.

J Immunol. 2001 Jan 1;166(1):89-94.

17.

Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy.

Lin SJ, Kuo ML.

Pediatr Hematol Oncol. 2011 Nov;28(8):640-6. doi: 10.3109/08880018.2011.613092. Epub 2011 Oct 4. Review.

PMID:
21970456
18.

Conversion of adipose-derived stem cells into natural killer-like cells with anti-tumor activities in nude mice.

Ning H, Lei HE, Xu YD, Guan RL, Venstrom JM, Lin G, Lue TF, Xin Z, Lin CS.

PLoS One. 2014 Aug 27;9(8):e106246. doi: 10.1371/journal.pone.0106246. eCollection 2014.

19.

Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.

Ayello J, van de Ven C, Fortino W, Wade-Harris C, Satwani P, Baxi L, Simpson LL, Sanger W, Pickering D, Kurtzberg J, Cairo MS.

Biol Blood Marrow Transplant. 2006 Jun;12(6):608-22.

20.

Selective expansion and engraftment of human CD16+ NK cells in NOD/SCID mice.

Harada H, Suzu S, Ito T, Okada S.

Eur J Immunol. 2005 Dec;35(12):3599-609.

Supplemental Content

Support Center